GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies: Buys back 19,13,660 shares
BUYBACK ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 13 Oct 2026, 05:56 PM IST  ·  BSE ID: 6ccf0eb6-111b-41fc-bac5-fdbf2b864df1
View Original BSE Filing (PDF)
💡
In Simple Terms
The company bought back a portion of its own shares from the stock market on October 13, 2026.
🤖 AI Summary
  • Advanced Enzyme Technologies bought back 46,178 shares on October 13, 2026.
  • The average acquisition price per share was ₹266.8579, excluding transaction costs.
  • Cumulative shares bought back as of October 13, 2026, total 19,13,660.
  • The buyback is conducted from the open market through stock exchanges.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares bought back on October 13, 2026
46,178
Average Price of acquisition
266.8579 ₹
Cumulative Equity Shares bought back as on October 13, 2026
19,13,660
🏢 How This Affects the Company
💰
Financial Impact
The buyback reduces the number of outstanding shares, potentially increasing earnings per share for remaining shareholders.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders.
👤
Who Is Affected
All shareholders are affected as the number of outstanding shares decreases, potentially impacting ownership percentages.
🔍
Management Signal
Management is utilizing cash reserves to return value to shareholders by reducing share count.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next daily buyback report disclosure.
Company's next quarterly financial results.
Total shares bought back versus buyback target.
LOW RISK Buyback is conducted as per SEBI regulations through stock exchanges.
💡 Investor Takeaway
Advanced Enzyme Technologies bought back 46,178 shares on October 13, 2026, at an average price of ₹266.8579. Cumulative buyback reached 19,13,660 shares.
⚖️ Strengths & Concerns

✅ Positives

  • Company actively managing its capital structure through share buybacks.
  • Consistent execution of buyback program as per SEBI regulations.
📅 Company Track Record
Past buyback activity includes 58,774 shares on Sep 1, 2026, at ₹296.0490, and 26,000 shares on Oct 7, 2026, at ₹272.3684.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many shares did Advanced Enzyme Technologies buy back on October 13, 2026?
Advanced Enzyme Technologies bought back 46,178 equity shares on October 13, 2026.
What was the average acquisition price per share on October 13, 2026?
The average acquisition price per share was ₹266.8579, excluding transaction costs.
What is the total number of shares bought back cumulatively by Advanced Enzyme Technologies?
As of October 13, 2026, the total number of equity shares bought back is 19,13,660.
Which broker executed the buyback transaction on October 13, 2026?
Emkay Global Financial Services Limited executed the buyback, buying 46,178 shares on the BSE.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.